Product Details:
| Strength | 50 mg |
| Formulation Type | Pegylated Liposomal |
| Form Of Medicine | Lyophilized |
| Brand | pegadria |
| Manufacturer | Pfizer |
| Storage Condition | Room Temperature |
| Shelf Life | 36 months |
| Pharmacopoeia Standard | IP |
| Packaging Size | 5 ml |
| Composition | Doxorubicin Hydrochloride |
Pegadria 50 Mg Injection is an anti-cancer medication containing liposomal doxorubicin, used to treat breast cancer, ovarian cancer, AIDS-related Kaposi’s sarcoma, and multiple myeloma. It acts by inhibiting cancer cell growth. It is often used when other treatments fail, sometimes in combination with other chemotherapy drugs.